Chimeric Therapeutics Limited (ASX: CHM) – Initiating Coverage


December 16, 2021
 / 
Chimeric Therapeutics Limited (ASX: CHM) is a clinical stage cell therapy company. CHM commenced trading on the ASX on 18 January 2021. The Company raised $35m through the issue ................